91ÌÒÉ«

Biomarkers of ageing are essential tools for human longevity trials, as they are needed to study whether an intervention slows human ageing. They also hold clinical promise because the biological age of a person or of an individual organ such as muscle, heart or brain is one of the strongest predictors of disease risk and mortality.

This symposium brings together leading experts on ageing biomarkers and longevity research to discuss state-of-the-art methods to quantify biological and organ-specific ageing. We will also present first data from the "TauAge" clinical trial designed to find out whether taurine slows human ageing.